logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
P

Paula R. Pohlmann

the university of texas m d anderson cancer center
H指数:31
被引数:4,460

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Zanidatamab in patients with early stage HER2-positive breast cancer: the NeoZanHER phase 2 single-arm open-label trial

赞尼达他马单抗在早期HER2阳性乳腺癌患者中的应用：NeoZanHER二期单臂开放标签试验

Nature Communications
IF15.7
2026-08-220
OAAI
Vicente Valero; Paula R. Pohlmann; Jason Mouabbi; Xuelin Huang; Wei Qiao; Heather Alonzo; Rashmi K. Murthy; Gaiane M. Rauch; Taiwo Adesoye; Cristina Checka; Fraser W. Symmans; Dmitrii Grachev; Flora Alajajyan; Adaeze Nwosu-Iheme; Amy Hassan; Miral Patel; Sharon H. Giordano; Kelly Hunt; Debasish Tripathy; Funda Meric-Bernstam
Telemedicine as a Gateway to Early-Phase Oncology Trials: Lessons from 14,000 Patients and Future Directions for Global Access and Equity

远程医疗作为早期肿瘤学试验的门户：来自14,000名患者的经验教训及全球可及性与公平性的未来方向

The Oncologist
IF0
2026-03-130
OA
Carlos Torrado, MD; Clark R Andersen, MS; Lei Kang; Amanda L Brink; Taiwo Adesoye, MD, MDH; Hung Le; Clover J Patterson, APRN; Anna Poullard, APRN; Jessica A Osburn, APRN; Harold N Tan, MD; Mohamed A Gouda, MD; Sheena Charles, APRN; Gabriele E Urschel, APRN; Tin-Yun Tang, MD, PhD; David S Hong, MD; Stephane Champiat, MD; Aung Naing, MD; Apostolia M Tsimberidou, MD, PhD; Ecaterina E Dumbrava, MD; Sarina A Piha-Paul, MD; Jordi Rodon, MD, PhD; Timothy A Yap, MBBS, PhD; Paula R Pohlmann, MD, PhD; Funda Meric-Bernstam, MD, PhD; Siqing Fu, MD, PhD
Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors

循环肿瘤DNA细化新辅助治疗耐药乳腺肿瘤的危险分层

Nature Communications
IF15.7
2025-12-090
OAAI
Mark Jesus M. Magbanua; Nayelis A. Manon; Denise M. Wolf; Samuel Rivero-Hinojosa; Ziad Ahmed; Rosalyn W. Sayaman; Antony Tin; Derrick Renner; Ekaterina Kalashnikova; Lamorna Brown-Swigart; Gillian L. Hirst; Christina Yau; Wen Li; Claudine Isaacs; Rebecca A. Shatsky; Amy S. Clark; Alexandra Zimmer; Amy L. Delson; Angel Rodriguez; Minetta C. Liu; Paula R. Pohlmann; Laura J. Esserman; Hope S. Rugo; Angela DeMichele; Laura van ‘t Veer
ASO Visual Abstract: Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial

ASO视觉摘要：多中心新辅助I-SPY2试验中，根据自报种族对腋窝手术管理的差异

Annals of Surgical Oncology
IF3.5
2025-08-210
PRE
M. Kaur; K. Dimitroff; J. C. Boughey; L. J. Esserman; C. Yau; J. Tchou; A. Quirarte; M. C. Lee; M. M. Howard-McNatt; K. Switalla; H. Kuerer; C. Sauder; L. M. Postlewait; C. Arciero; Roshni Rao; A. Wallace; C. Reyna; K. Ahmed; L. Gutnik; N. Taunk; J. Perlmutter; A. DeMichele; D. Yee; N. M. Hylton; F. Symmans; H. S. Rugo; R. A. Shatsky; C. Isaacs; S. Rudra; P. Pohlmann; C. Ewing; J. Wong; M. Alvarado; N. Jaskowiak; N. Prionas; M. Golshan; M. A. Piltin; O. I. Olopade; R. A. Mukhtar
Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial

在多中心新辅助I-SPY2试验中，基于自我识别种族的腋窝手术管理差异

Annals of Surgical Oncology
IF3.5
2025-07-230
OA
Mandeep Kaur; Katrina Dimitroff; Judy C. Boughey; Laura J. Esserman; Christina Yau; Julia Tchou; Astrid Quirarte; Marie Catherine Lee; Marissa M. Howard-McNatt; Kayla Switalla; Henry Kuerer; Candice Sauder; Lauren M. Postlewait; Cletus Arciero; Roshni Rao; Anne Wallace; Chantal Reyna; Kamran Ahmed; Lily Gutnik; Neil Taunk; Jane Perlmutter; Angela DeMichele; Douglas Yee; Nola M. Hylton; W. Fraser Symmans; Hope S. Rugo; Rebecca A. Shatsky; Claudine Isaacs; Sonali Rudra; Paula Pohlmann; Cheryl Ewing; Jasmine Wong; Michael Alvarado; Nora Jaskowiak; Nicolas Prionas; Mehra Golshan; Mara A. Piltin; Olufunmilayo I. Olopade; Rita A. Mukhtar
Pathologic complete response (pCR) rates for patients with HRD/HER2L high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trial

在I-SPY2临床试验中，根据临床和分子特征，HRD/HER2L高风险早期乳腺癌（EBC）患者的病理完全缓解（pCR）率。

ANNALS OF ONCOLOGY
IF65.4
2025-02-012
PRE
Huppert, L. A.; Wolf, D.; Yau, C.; Brown-Swigart, L.; Hirst, G. L.; Isaacs, C.; Pusztai, L.; Pohlmann, P. R.; Demichele, A.; Shatsky, R.; Yee, D.; Thomas, A.; Nanda, R.; Perlmutter, J.; Heditsian, D.; Hylton, N.; Symmans, F.; van't Veer, L. J.; Esserman, L.; Rugo, H. S.
Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Datopotamab-deruxtecan治疗早期乳腺癌: 序贯多重分配随机I-SPY2.2 2期试验

NATURE MEDICINE
IF50
2024-09-141
PRE
Khoury, Katia; Meisel, Jane L.; Yau, Christina; Rugo, Hope S.; Nanda, Rita; Davidian, Marie; Tsiatis, Butch; Chien, A. Jo; Wallace, Anne M.; Arora, Mili; Rozenblit, Mariya; Hershman, Dawn L.; Zimmer, Alexandra; Clark, Amy S.; Beckwith, Heather; Elias, Anthony D.; Stringer-Reasor, Erica; Boughey, Judy C.; Nangia, Chaitali; Vaklavas, Christos; Omene, Coral; Albain, Kathy S.; Kalinsky, Kevin M.; Isaacs, Claudine; Tseng, Jennifer; Torres, Evanthia T. Roussos; Thomas, Brittani; Thomas, Alexandra; Sanford, Amy; Balassanian, Ronald; Ewing, Cheryl; Yeung, Kay; Sauder, Candice; Sanft, Tara; Pusztai, Lajos; Trivedi, Meghna S.; Outhaythip, Ashton; Li, Wen; Onishi, Natsuko; Asare, Adam L.; Beineke, Philip; Norwood, Peter; Brown-Swigart, Lamorna; Hirst, Gillian L.; Matthews, Jeffrey B.; Moore, Brian; Symmans, W. Fraser; Price, Elissa; Beedle, Carolyn; Perlmutter, Jane; Pohlmann, Paula; Shatsky, Rebecca A.; Demichele, Angela; Yee, Douglas; van't Veer, Laura J.; Hylton, Nola M.; Esserman, Laura J.
Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Datopotamab-deruxtecan联合durvalumab治疗早期乳腺癌: 序贯多重分配随机I-SPY2.2 2期试验

NATURE MEDICINE
IF50
2024-09-144
PRE
Shatsky, Rebecca A.; Trivedi, Meghna S.; Yau, Christina; Nanda, Rita; Rugo, Hope S.; Davidian, Marie; Tsiatis, Butch; Wallace, Anne M.; Chien, A. Jo; Stringer-Reasor, Erica; Boughey, Judy C.; Omene, Coral; Rozenblit, Mariya; Kalinsky, Kevin; Elias, Anthony D.; Vaklavas, Christos; Beckwith, Heather; Williams, Nicole; Arora, Mili; Nangia, Chaitali; Torres, Evanthia T. Roussos; Thomas, Brittani; Albain, Kathy S.; Clark, Amy S.; Falkson, Carla; Hershman, Dawn L.; Isaacs, Claudine; Thomas, Alexandra; Tseng, Jennifer; Sanford, Amy; Yeung, Kay; Boles, Sarah; Chen, Yunni Yi; Huppert, Laura; Jahan, Nusrat; Parker, Catherine; Giridhar, Karthik; Howard, Frederick M.; Blackwood, M. Michele; Sanft, Tara; Li, Wen; Onishi, Natsuko; Asare, Adam L.; Beineke, Philip; Norwood, Peter; Brown-Swigart, Lamorna; Hirst, Gillian L.; Matthews, Jeffrey B.; Moore, Brian; Symmans, W. Fraser; Price, Elissa; Heditsian, Diane; Lestage, Barbara; Perlmutter, Jane; Pohlmann, Paula; Demichele, Angela; Yee, Douglas; van 't Veer, Laura J.; Hylton, Nola M.; Esserman, Laura J.
The impact of changes in tumor mutational landscape during neoadjuvant therapy on tumor-informed ctDNA testing in breast cancer patients

新辅助治疗期间肿瘤突变谱变化对肿瘤信息ctDNA检测在乳腺癌患者中的影响

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Magbanua, M.; Rivero-Hinojosa, S.; Sayaman, R.; Tin, T.; Kalashnikova, E.; Wolf, D.; Brown-Swigart, L.; Hirst, G.; Yau, C.; Isaacs, C.; Shatsky, R. A.; Delson, A.; Palsuledesai, C. C.; Rodriguez, A. A.; Liu, M. C.; Pohlmann, P. R.; Esserman, L.; Rugo, H. S.; DeMichele, A.; Van't Veer, L. J.
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study (vol 15, 2691, 2024)
NATURE COMMUNICATIONS
IF15.7
2024-05-100
OAAI
Lynce, Filipa; Mainor, Candace; Donahue, Renee N.; Geng, Xue; Jones, Greg; Schlam, Ilana; Wang, Hongkun; Toney, Nicole J.; Jochems, Caroline; Schlom, Jeffrey; Zeck, Jay; Gallagher, Christopher; Nanda, Rita; Graham, Deena; Stringer-Reasor, Erica M.; Denduluri, Neelima; Collins, Julie; Chitalia, Ami; Tiwari, Shruti; Nunes, Raquel; Kaltman, Rebecca; Khoury, Katia; Gatti-Mays, Margaret; Tarantino, Paolo; Tolaney, Sara M.; Swain, Sandra M.; Pohlmann, Paula; Parsons, Heather A.; Isaacs, Claudine
Phase 2 study of novel HER2-targeting, TLR7/8 immune-stimulating antibody conjugate (ISAC) BDC-1001+/- pertuzumab in patients with HER2-positive metastatic breast cancer (MBC) previously treated with trastuzumab deruxtecan
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Pegram, Mark; Calfa, Carmen; Chen, Chris; Salgado, Alfonso Cortes; Heeke, Arielle; Kang, Irene; Pistilli, Barbara; Pohlmann, Paula; Rugo, Hope; Saura, Cristina; Vicier, Cecile; Pearson, Cecelia I.; Tapia, Coya; Yin, Ming; Yu, Tai; Alonso, Michael N.; Perez, Edith A.; Drago, Joshua
Translational insights from a phase 1, first-in-human (FIH) clinical trial of the anti-HER2 CAR macrophage CT-0508 in participants with HER2 positive metastatic breast cancer and other HER2 overexpressing solid tumors
CANCER RESEARCH
IF16.6
2024-05-021
PRE
Abdou, Yara; Mortimer, Joanne; Pohlmann, Paula; Johnson, Melissa; Maziarz, Richard; Specht, Jennifer M.; Dees, Claire; Ueno, Naoto; Yuan, Yuan; Angelos, Mathew; Gill, Saar; Shestova, Olga; Serody, Jonathon; Priceman, Saul; Qureshi, Rehman; Sonawane, Poonam; Pierini, Stefano; Oliveira-Nunes, Maria Cecilia; Cushing, Daniel; Klichinsky, Michael; Condamine, Thomas; Swaby, Ramona; Reiss, Kim
NCI10217: Phase Ib biomarker-driven tumor-agnostic combination (Combo) trial of copanlisib (Copa) and olaparib (Ola) in molecularly-selected patients (pts) with advanced cancers with PIK3CA hotspot, PTEN and DNA damage response (DDR) mutations
CANCER RESEARCH
IF16.6
2024-04-050
PRE
Yap, Timothy A.; Dumbrava, Ecaterina E.; Ahnert, Jordi Rodon; Tsimberidou, Apostolia M.; Hong, David; Piha-Paul, Sarina A.; Karp, Daniel D.; Fu, Siqing; Naing, Aung; Pohlmann, Paula; Rhudy, Jessica R.; Berenji-Jalaei, Sheila B.; Cole, Ashley A.; Valladolid, Christian; Dufner, Desirae; Bockorny, Bruno B.; Bullock, Andrea; Fein, Daniel; Buchbinder, Elizabeth; Choudhury, Atish; Haddox, Candace; Lee, Elizabeth; Wulf, Gerburg; Ivy, Percy; Said, Rabih; Shapiro, Geoffrey; Meric-Bernstam, Funda
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study
NATURE COMMUNICATIONS
IF15.7
2024-03-274
OAAI
Lynce, Filipa; Mainor, Candace; Donahue, Renee N.; Geng, Xue; Jones, Greg; Schlam, Ilana; Wang, Hongkun; Toney, Nicole J.; Jochems, Caroline; Schlom, Jeffrey; Zeck, Jay; Gallagher, Christopher; Nanda, Rita; Graham, Deena; Stringer-Reasor, Erica M.; Denduluri, Neelima; Collins, Julie; Chitalia, Ami; Tiwari, Shruti; Nunes, Raquel; Kaltman, Rebecca; Khoury, Katia; Gatti-Mays, Margaret; Tarantino, Paolo; Tolaney, Sara M.; Swain, Sandra M.; Pohlmann, Paula; Parsons, Heather A.; Isaacs, Claudine
Comprehensive genomic and transcriptomic analysis to guide therapy for patients with metastatic solid tumors
CANCER RESEARCH
IF16.6
2024-03-220
PRE
Uzunparmak, Burak; Su, Fei; Johnson, Amber M.; Nomie, Krystle; Fowler, Nathan; Kontselidze, Lile; Bagaev, Aleksander; Butusova, Anna; Dumbrava, Ecaterina E.; Rodon-Ahnert, Jordi; Fu, Siqing; Hong, David S.; Yap, Timothy A.; Naing, Aung; Piha-Paul, Sarina A.; Karp, Daniel D.; Pohlmann, Paula R.; Tsimberidou, Apostolia M.; Patel, Keyur P.; Meric-Bernstam, Funda

研究方向

暂未获取到该数据
C
Claudine Isaacs
H 指数:97论文数:751被引数:3.7万
F
Filipa Lynce
H 指数:29论文数:262被引数:4,831
S
Sandra M. Swain
H 指数:87论文数:561被引数:5.1万
L
Laura J. Esserman
H 指数:89论文数:990被引数:3.3万
R
Rita Nanda
H 指数:56论文数:548被引数:1.6万
H
Hope S. Rugo
H 指数:137论文数:1,616被引数:10.0万
C
Christina Yau
H 指数:92论文数:571被引数:7.9万
G
Gillian L. Hirst
H 指数:29论文数:279被引数:5,593
A
Angela DeMichele
H 指数:89论文数:736被引数:2.8万
L
Lamorna Brown Swigart
H 指数:36论文数:290被引数:8,418